West Pharma expanding plant for making wearable injectors; Will cancer become a chronic condition?;

> West Pharmaceutical Services ($WST) is expanding its Scottsdale, AZ, facility to increase production of its SmartDose Electronic Wearable Injector. The device adheres to the patient's abdomen to deliver pre-programmed volumes of drug. More

> Researchers have designed a method of evaluating the performance of various polymer drug-delivery formulations thanks to imaging via luminescent quantum dots. More

> Dr. Julia Ljubimova, the director of the Nanomedicine Research Center at Cedars-Sinai in Los Angeles, envisions using nanotechnology to turn cancer into a chronic condition, akin to diabetes. More

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.